Post-Approval Study to Investigate the Long Term (8 Year) Survivorship of

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01284283` - 2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use	N/A
	Active, not recruiting	`NCT00804388` - Wear Measurements of E-Poly in an Uncemented THA With Either 32 or 36 mm Caput of Ceramics.	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01284283 - 2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use

N/A

Active, not recruiting

NCT00804388 - Wear Measurements of E-Poly in an Uncemented THA With Either 32 or 36 mm Caput of Ceramics.

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01288586
Study type	Observational
Source	Stryker Trauma GmbH
Contact
Status	Completed
Phase	N/A
Start date	October 5, 2009
Completion date	November 14, 2016

Post-Approval Study to Investigate the Long Term (8 Year) Survivorship of STAR Ankle Among Continued Access Study Patients — STAR 8

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms